Skip to main content
Paul Sax, MD, Infectious Disease, Boston, MA, Brigham and Women's Hospital

PaulEdwardSaxMD

Infectious Disease • Boston, MA

Professor, Medicine-Brigham & Women's Hospital, Harvard Medical School

Join to view full profile

Dr. Sax is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sax's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1990 - 1992
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1990
  • Harvard Medical School
    Harvard Medical SchoolClass of 1987
  • Harvard University
    Harvard UniversityB.A., English, Cum Laude, 1982

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1989 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Distinguished Clinical Faculty Award Brigham and Women's Hospital, 2016
  • Kenneth Kaplan Infectious Diseases Clinician Award Massachusetts Infectious Diseases Society, 2014
  • America's Top Doctors Castle Connolly, 2004-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Is Non-Inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive Adults with Human Immun...  
    George J Hanna, Peter Sklar, Kathleen E Squires, Paul E Sax, Carey Hwang, Clinical Infectious Diseases
  • Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders  
    Walsh CE, Workowski K, Terrault NA, Sax PE, Cohen A, Bowlus CL, Kim AY, Hyland RH, Han B, Wang J, Stamm LM, Brainard DM, McHutchison JG, von Drygalski A, Rhame F, Frie..., Haemophilia, 1/25/2017
  • Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?  
    Koullias Y, Sax PE, Fields NF, Walensky RP, Hyle EP, Clin Infect Dis, 1/12/2017
  • Join now to see all

Books/Book Chapters

  • Depression in Medical Illness 
    Chapter: Depression and Infectious Diseases 
    Grimaldi J, Harder J, Oser M, and Sax PEEditors: Barsky AJ and Silbersweig DA.McGraw-Hill, New York, NY2017
  • HIV Essentials 
    Sax PE, Cohen CJ, and Kuritzkes DRJones and Bartlett PublishersEdition 7th,2014
  • Principles and Practice of Hospital Medicine 
    Chapter: Approach to the Patient with HIV 
    Farel CF and Sax PEEditors: McKean SM, Ross JJ, Ginsberg J, Dressler D, Brotman D.McGraw-Hill, New York, NY2012
  • Join now to see all

Lectures

  • Review of Conference on Retroviruses and Opportunistic Infections 
    1/1/2017
  • Treatment Update from International AIDS Society Meeting 
    1/1/2017
  • Update from the Conference on Retroviruses and Opportunistic Infections 
    1/1/2017
  • Join now to see all

Other

  • ClinicalQuiz™: So You Think You’re an HIV Expert 
    Sax PE, Daar ES, Eron JJ, Gallant JE, Hodder S, and Powderly WG, Clinical Care Options
    http://www.clinicaloptions.com/HIV/Treatment%20Updates/HIV%20Quiz/Module/Module_1.asp
    1/1/2013
  • Answering the Questions: Initiating Antiretroviral Therapy 
    Sax PE, Clinical Care Options
    1/9/2009
  • Key Principles and Recommended Regimens for First-Line Antiretroviral Therapy 
    Sax PE, Clinical Care Options InPractice
    http://www.clinicaloptions.com/inPractice.aspx
    1/1/2009
  • Join now to see all

Press Mentions

  • Steroid Drug Reduces Death Rate in Severe Pneumonia, Study Shows
    Steroid Drug Reduces Death Rate in Severe Pneumonia, Study ShowsMarch 21st, 2023
  • Have the Odds of Getting Long COVID Changed?
    Have the Odds of Getting Long COVID Changed?February 24th, 2023
  • COVID Is Still Killing People Every Day. But Its Main Victims Have Changed
    COVID Is Still Killing People Every Day. But Its Main Victims Have ChangedFebruary 20th, 2023
  • Join now to see all

Grant Support

  • The Setpoint Study: Does Early Therapy Alter The Virologic Setpoint?National Center For Research Resources2007–2008
  • HIV-1 DNA Vrc-Hiv 009-00 VP (Gag-Pol-Nef_multiclade Env) In HIV-1National Center For Research Resources2007–2008
  • ALLRT: Adult AIDS Clinical Trials Group Longitudinal Linked Randomized TrialsNational Center For Research Resources2007–2008
  • A5202: A Phase III Trial Of Open-Label Efavirenz Or Atazanavir With RitonavirNational Center For Research Resources2007–2008
  • A Phase IV Study Of Antiretroviral Therapy For Hiv-Infected AdultsNational Center For Research Resources2007–2008
  • HIV-1 DNA Vrc-Hiv 009-00 VP (Gag-Pol-Nef-Multiclade Env) In HIV-1National Center For Research Resources2006
  • Randomized, Double Blind, Parallel Study Of Ro31-8959 Alone (Type D)National Center For Research Resources1996
  • Delavirdine Mesylate In Combination With Didovudine VS Didovudine AloneNational Center For Research Resources1996
  • Devavirdine Mesylate In Combination With Didanosine VS DidanosineNational Center For Research Resources1995
  • Delavirdine Mesylate In Combination With Zidovudine VS ZidovudineNational Center For Research Resources1995
  • Prophylaxis Against TB In Patients With HIV InfectionNational Center For Research Resources1994–1995

Hospital Affiliations

Dr. Paul Sax, Dr. Paul Sax, MD, Dr. P Sax, Dr. Paul Edward Sax